Progressive oxidative damage in the central nervous system of a murine model for juvenile batten disease

Journal of Neuroscience Research

Volumn 85, Issue 13, 2007, Pages 2882-2891

  Benedict, Jared W ^a   Sommers, Crosby A ^a   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Batten disease; Neuronal ceroid lipofuscinosis; Oxidative stress

Indexed keywords

GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE;

ANIMAL MODEL; ARTICLE; BRAIN REGION; CEREBELLUM; CLN3 GENE; CONTROLLED STUDY; DISEASE COURSE; GENE FUNCTION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MOTOR CORTEX; MOUSE; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; OXIDATION-REDUCTION; PEROXIREDOXINS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE;

EID: 34948886661     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21416     Document Type: Article

References (50)

1. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. 2001. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103:373-383.
2. Autti T, Raininko R, Vanhanen SL, Santavuori P. 1996. MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology 38:476-482.
3. Baker MA, Cerniglia GJ, Zaman A. 1990. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190:360-365.
4. Bizzozero OA, Ziegler JL, De Jesus G, Bolognani F. 2006. Acute depletion of reduced glutathione causes extensive carbonylation of rat brain proteins. J Neurosci Res 83:656-667.
5. Block ML, Hong JS. 2005. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77-98.
6. Boillee S, Vande Velde C, Cleveland DW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59.
7. Brooks AI, Chattopadhyay S, Mitchison HM, Nussbaum RL, Pearce DA. 2003. Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease. Mol Genet Metab 78:17-30.
8. Cao Y, Espinola JA, Fossale E, Massey AC, Cuervo AM, MacDonald ME, Cotman SL. 2006. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J Biol Chem 281:20483-20493.
9. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. 2003. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23-38.
10. Das AM, Jolly RD, Kohlschutter A. 1999. Anomalies of mitochondrial ATP synthase regulation in four different types of neuronal ceroid lipofuscinosis. Mol Genet Metab 66:349-355.
11. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52:381-389.
12. Dringen R, Gutterer JM, Hirrlinger J. 2000. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912-4916.
13. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. 2004. S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 8:201-212.
14. Golabek AA, Kida E, Walus M, Kaczmarski W, Michalewski M, Wisniewski KE. 2000. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells. Mol Genet Metab 70:203-213.
15. Guarneri R, Russo D, Cascio C, D'Agostino S, Galizzi G, Bigini P, Mennini T, Guarneri P. 2004. Retinal oxidation, apoptosis and age-and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis. Brain Res 1014:209-220.
16. Hald A, Lotharius J. 2005. Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol 193:279-290.
17. Hall AG. 1999. Review: the role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29:238-245.
18. Halliwell B. 2006. Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634-1658.
19. Heine C, Tyynela J, Cooper JD, Palmer DN, Elleder M, Kohlschutter A, Braulke T. 2003. Enhanced expression of manganese-dependent superoxide dismutase in human and ovine CLN6 tissues. Biochem J 376:369-376.
20. Holopainen JM, Saarikoski J, Kinnunen PK, Jarvela I. 2001. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). Eur J Biochem 268:5851-5856.
21. International Batten Disease Consortium. 1995. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell 82:949-957.
22. Jezek P, Hlavata L. 2005. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37:2478-2503.
23. Kirveskari E, Partinen M, Salmi T, Sainio K, Telakivi T, Hamalainen M, Larsen A, Santavuori P. 2000. Sleep alterations in juvenile neuronal ceroid-lipofuscinosis. Pediatr Neurol 22:347-354.
24. Kovacs AD, Weimer JM, Pearce DA. 2006. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol Dis 22:575-585.
25. Lauronen L, Heikkila E, Autti T, Sainio K, Huttunen J, Aronen HJ, Korvenoja A, Ilmoniemi RJ, Santavuori P. 1997. Somatosensory evoked magnetic fields from primary sensorimotor cortex in juvenile neuronal ceroid lipofuscinosis. J Child Neurol 12:355-360.
26. Lindenau J, Noack H, Possel H, Asayama K, Wolf G. 2000. Cellular distribution of superoxide dismutases in the rat CNS. Glia 29:25-34.
27. Luiro K, Kopra O, Blom T, Gentile M, Mitchison HM, Hovatta I, Tornquist K, Jalanko A. 2006. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. J Neurosci Res 84:1124-1138.
28. Markesbery WR, Lovell MA. 1998. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19:33-36.
29. Meister A, Anderson ME. 1983. Glutathione. Annu Rev Biochem 52:711-760.
30. Mitchison HM, Bernard DJ, Greene ND, Cooper JD, Junaid MA, Pullarkat RK, de Vos N, Breuning MH, Owens JW, Mobley WC, Gardiner RM, Lake BD, Taschner PE, Nussbaum RL. 1999. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol Dis 6:321-334.
31. Mytilineou C, Kokotos Leonardi ET, Kramer BC, Jamindar T, Olanow CW. 1999. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J Neurochem 73:112-119.
32. Nardocci N, Verga ML, Binelli S, Zorzi G, Angelini L, Bugiani O. 1995. Neuronal ceroid-lipofuscinosis: a clinical and morphological study of 19 patients. Am J Med Genet 57:137-141.
33. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. 2006. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65:631-641.
34. Persaud-Sawin DA, Boustany RM. 2005. Cell death pathways in juvenile Batten disease. Apoptosis 10:973-985.
35. Persaud-Sawin DA, VanDongen A, Boustany RM. 2002. Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis. Hum Mol Genet 11:2129-2142.
36. Phillips SN, Benedict JW, Weimer JM, Pearce DA. 2005. CLN3, the protein associated with batten disease: structure, function and localization. J Neurosci Res 79:573-583.
37. -/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res 1023:231-242.
38. Pontikis CC, Cotman SL, MacDonald ME, Cooper JD. 2005. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease. Neurobiol Dis 20:823-836.
39. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA. 2005. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice - a model of familial Parkinson's disease. Neurobiol Dis 18:492-498.
40. Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS. 2002. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83:973-983.
41. Ramirez-Montealegre D, Pearce DA. 2005. Defective lysosomal arginine transport in juvenile Batten disease. Hum Mol Genet 14:3759-3773.
42. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
43. Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-4911.
44. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD. 1994. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348-355.
45. Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santorelli FM, Piemonte F. 2006. Protein glutathionylation in human central nervous system: potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res 83:256-263.
46. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA. 2006. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27:1564-1576.
47. Vesce S, Jekabsons MB, Johnson-Cadwell LI, Nicholls DG. 2005. Acute glutathione depletion restricts mitochondrial ATP export in cerebellar granule neurons. J Biol Chem 280:38720-38728.
48. Weimer JM, Kriscenski-Perry E, Elshatory Y, Pearce DA. 2002. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromol Med 1:111-124.
49. Weimer JM, Custer AW, Benedict JW, Alexander NA, Kingsley E, Federoff HJ, Cooper JD, Pearce DA. 2006. Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Neurobiol Dis 22:284-293.
50. Wong GH, Goeddel DV. 1988. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242:941-944.